Hostname: page-component-cd9895bd7-p9bg8 Total loading time: 0 Render date: 2024-12-22T16:36:53.745Z Has data issue: false hasContentIssue false
  • English
  • Français

Metabolic syndrome: what is it and what are the implications?

Published online by Cambridge University Press:  07 March 2007

D. I. Shaw ,
W. L. Hall  and
C. M. Williams
D. I. Shaw*
Affiliation:
Hugh Sinclair Unit of Human Nutrition, School of Food Biosciences, University of Reading, Reading, RG6 6AP, UK
W. L. Hall
Affiliation:
Hugh Sinclair Unit of Human Nutrition, School of Food Biosciences, University of Reading, Reading, RG6 6AP, UK
C. M. Williams
Affiliation:
Hugh Sinclair Unit of Human Nutrition, School of Food Biosciences, University of Reading, Reading, RG6 6AP, UK
*
*Corresponding author: Ms D. Shaw, fax + 44 118 9318703, [email protected]
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Obesity and overweight are linked with a cluster of metabolic and vascular disorders that have been termed the metabolic syndrome. Although there is not yet a universally-accepted set of diagnostic criteria, most expert groups agree that the syndrome is characterised by impaired insulin sensitivity and hyperglycaemia, dyslipidaemia (elevated blood triacyglycerols with depressed HDL-cholesterol), abdominal obesity and hypertension. Based on existing published criteria estimates suggest that the syndrome affects a substantial percentage of the middle-aged and elderly populations of most European countries (10–20%) and confers increased risk of type 2 diabetes (2–8.8-fold) and CVD (1.5–6-fold), as well as having a marked effect on morbidity. Although the pathophysiology is incompletely understood, insulin resistance and abdominal obesity are central to subsequent abnormalities in circulating glucose and lipoproteins, and vascular function that lead to type 2 diabetes, atherosclerosis and CVD. The link between metabolic syndrome, type 2 diabetes and CVD, as well as inability to reverse the present rising rates of obesity, will lead to economically-unsustainable costs of health care in the next 10–20 years. Preventative strategies for metabolic syndrome are required to slow rates of progression and to reduce dependence on costly medical management. A notable development is recent evidence that shows that diet and exercise are more effective than drug treatment in preventing the development of type-2 diabetes in high-risk individuals. The LIPGENE project will investigate dietary fat quality as a strategy for the prevention of metabolic syndrome and identify food chain approaches that can support consumer attempts to alter their dietary patterns.

Keywords

Metabolic syndromePrevalenceGenderPathophysiologyDefinition
Type
Meeting Report
Information
Proceedings of the Nutrition Society , Volume 64 , Issue 3 , August 2005 , pp. 349 - 357
Copyright
Copyright © The Nutrition Society 2005

References

Alexander, C, Landsman, P, Teutsch, S & Haffner, S (2003) NCEP-defined metabolic syndrome, diabetes and the prevalence of coronary heart disease among NHANES III participants age 50 years and older. Diabetes 52, 1210–1214.Google Scholar
Ascaso, J, Romero, P, Real, J, Lorente, R, Martinez-Valls, J & Carmena, R (2003) Abdominal obesity, insulin resistance, and metabolic syndrome in a southern European population. European Journal of Internal Medicine 14, 101–106.Google Scholar
Balkau, B & Charles, M (1999) Comment on the provisional report from the WHO consultation. Diabetic Medicine 16, 442–443.Google Scholar
Balkau, B, Vernay, M, Mhamdi, L, Novak, M, Arondel, D, Vol, S, Tichet, J & Eshwege, E (2003) The incidence and persistence of the NCEP (National Cholesterol Education Progam) metabolic syndrome. The French D.E.S.I.R. study. Diabetes Metabolism 29, 526–532.Google Scholar
Bonora, E, Kiechl, S, Willeit, J, Oberhollenzer, F, Egger, G, Bonadonna, R & Muggeo, M (2003) Prevalence, ancillary clinical features and cardiovascular disease in the metabolic syndrome: the Bruneck study. International Congress Series 1253, 13–17.Google Scholar
Carr, D, Utzschneider, K, Hull, R, Kodama, K, Retzlaff, B, Brunzell, J, Shofer, J, Fish, B, Knopp, R & Kahn, S (2004) Intra-abdominal fat is a major determinant of the National Cholesterol Education Program Adult Treatment Panel III criteria for the metabolic syndrome. Diabetes 53, 2087–2094.Google Scholar
Cefalu, W (2001) Insulin resistance: cellular and clinical concepts. Experimental Biology and Medicine 226, 13–26.Google Scholar
Chen, W, Srinivasan, S, Elkasabany, A & Berenson, G (1999) The association of cardiovascular risk factor clustering related to insulin resistance syndrome (Syndrome X) between young parents and their offspring: the Bogalusa Heart Study. Atherosclerosis 145, 197–205.Google Scholar
Cunnane, S & Griffin, B (2002) Nutrition and metabolism of lipids. In Introduction to Human Nutrition, pp. 81–115 [Gibney, M, Vorster, H and Kok, F, editors] Oxford: Blackwell Science.Google Scholar
Diabetes, UK (2004) Diabetes in the UK 2004 1 – 27 www.diabetes.org.uk/infocentre/reports/in_the_UK_2004.doc.Google Scholar
Dowse, G & Zimmet, P (1993) The thrifty genotype in non-insulin dependent diabetes. British Medical Journal 306, 532–533.Google Scholar
European Group for the Study of & Insulin Resistance (2002) Frequency of the WHO Metabolic Syndrome in European cohorts, and an alternative definition of an insulin resistance syndrome. Diabetes Metabolism 28, 364–376.Google Scholar
Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (2001) Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Journal of the American Medical Association 285, 2486–2497.CrossRefGoogle Scholar
Ford, E, Giles, W & Dietz, W (2002) Prevalence of the metabolic syndrome amongst US adults: findings from the Third National Health and Nutrition Examination Survey. Journal of the American Medical Association 287, 356–359.Google Scholar
Ford, ES (2004) The metabolic syndrome and mortality from cardiovascular disease and all causes: findings from the National Health and Nutrition Examination Survey II Mortality Study. Atherosclerosis 173, 309–314.Google Scholar
Grundy, S (2004a) Metabolic syndrome: Part I. Endocrinology and Metabolism Clinics of North America 33, ix–xi.Google Scholar
Grundy, S (2004b) Obesity, metabolic syndrome, and cardiovascular disease. Journal of Clinical Endocrinology and Metabolism 89, 2295–2600.Google Scholar
Haber, E, Ximenes, H, Procopio, J, Carvalho, C, Curi, R & Carpinelli, A (2002) Pleiotropic effects of fatty acids on pancreatic beta cells. Journal of Cellular Physiology 194, 1–12.Google Scholar
Hanson, R, Imperatore, G, Bennett, P & Knowler, W (2002) Components of the Metabolic Syndrome and incidence of type 2 diabetes. Diabetes 51, 3120–3127.Google Scholar
Hills, S, Balkau, B, Coppack, S, Dekker, J, Mari, A, Natali, A, Walker, M & Ferrannini, E (2004) The EGIR-RISC Study (The European group for the study of insulin resistance: relationship between insulin sensitivity and cardiovascular disease risk): 1. Methodology and objectives. Diabetologia 47, 566–570.Google Scholar
Hu, G, Qiao, Q, Tuomilehto, J, Balkau, B, Borch-Johnsen, K & Pyorala, K (2004) Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in nondiabetic European men and women. Archives of Internal Medicine 164, 1066–1076.Google Scholar
International Obesity Task Force (2004) IOTF Childhood Obesity Report http://www.iotf.org/media/IOTFmay28.pdf.Google Scholar
Isomaa, B, Almgren, P, Tuomi, T, Forsen, B, Lahti, K, Nissen, M, Taskinen, M & Groop, L (2001) Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 24, 683–689.CrossRefGoogle ScholarPubMed
James, P (2004) Obesity: The worldwide epidemic. Clinics in Dermatology 22, 276–280.Google Scholar
Kohen-Avramoglu, R, Theriault, A & Adeli, K (2003) Emergence of the metabolic syndrome in childhood: an epidemiological overview and mechanistic link to dyslipidaemia. Clinical Biochemistry 36, 413–420.CrossRefGoogle Scholar
Kraegen, E, Cooney, G, Ye, J & Fuler, S (2002) Peroxisome proliferator activated receptors, fatty acids and muscle insulin resistance. Journal of the Royal Society of Medicine 95, 14–22.Google Scholar
Laaksonen, D, Lakka, H, Niskanen, L, Kaplan, G, Salonen, J & Lakka, T (2002) Metabolic syndrome and development of diabetes mellitus: Application and validation of recently suggested definitions of the metabolic syndrome in a prospective cohort study. American Journal of Epidemiology 156, 1070–1077.Google Scholar
Lakka, H, Laaksonen, D, Lakka, T, Niskanen, L, Kumpulsalo, E, Tuomilehto, J & Salonen, J (2002) The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. Journal of the American Medical Association 288, 2709–2716.Google Scholar
Lobstein, T, Baur, L & Uauy, R (2004) Obesity in children and young people: a crisis in public health. Obesity Reviews 5, 4–85.Google Scholar
Malik, S, Wong, N, Franklin, S, Kamath, T, L'Italien, G, Pio, J & Williams, R (2004) Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation 110, 1245–1250.Google Scholar
Nestel, P (2004) Nutritional aspects in the causation and management of the metabolic syndrome. Endocrinology and Metabolism Clinics of North America 33, 483–492.Google Scholar
Ninomiya, J, L'Italien, G, Criqui, M, Whyte, J, Gamst, A & Chen, R (2004) Association of the metabolic syndrome with history of myocardial infarction and stroke in the third national health and nutrition examination survey. Circulation 109, 42–46.Google Scholar
Palaniappan, L, Carnethon, M, Wang, Y, Hanley, A, Fortmann, S, Haffner, S & Wagenknecht, L (2004) Predictors of the incident metabolic syndrome in adults. Diabetes Care 27, 788–793.Google Scholar
Panagiotakos, D, Pitsavos, C, Chrysohoou, C, Skoumas, J, Tousoulis, D, Toutouza, M, Toutouzas, P & Stefanadis, C (2004) Impact of lifestyle habits on the prevalence of the metabolic syndrome among Greek adults from the ATTICA study. American Heart Journal 147, 106–112.Google Scholar
Reaven, GM (1988) Role of insulin resistance in human disease. Diabetes 37, 1595–1600.Google Scholar
Resnick, H, Jones, K, Ruotolo, G, Jain, A, Henderson, J, Lu, W & Howard, B (2003) Insulin resistance, the metabolic syndrome, and risk of incident cardiovascular disease in nondiabetic American Indians. Diabetes Care 26, 861–867.CrossRefGoogle ScholarPubMed
Scuteri, A, Najjar, SS, Muller, DC, Andres, R, Hougaku, H, Metter, EJ & Lakatta, EG (2004) Metabolic syndrome amplifies the age-associated increases in vascular thickness and stiffness. Journal of the American College of Cardiology 43, 1388–1395.Google Scholar
Tan, C, Ma, S, Wai, D, Chew, S & Tai, E (2004) Can we apply the National Cholesterol Education Program Treatment Panel definition of the metabolic syndrome to Asians. Diabetes Care 27, 1182–1186.Google Scholar
van Oostrom, A, Cabezas, M & Rabelink, T (2002) Insulin resistance and vessel endothelial function. Journal of the Royal Society of Medicine 95, 54–61.Google ScholarPubMed
Vessby, B, Uusitupa, M, Hermansen, K, Riccardi, G, Rivellese, A, Tapsell, L et al. (2001) Substituting dietary saturated for monounsaturated fat impairs insulin sensitivity in healthy men and women: The KANWU study. Diabetologia 44, 312–319.Google Scholar
Weiss, R, Dzlura, J, Burgert, T, Tamborlane, W, Taksali, S, Yeckel, C et al. (2004) Obesity and the metabolic syndrome in children and adolescents. New England Journal of Medicine 350, 2362–2374.Google Scholar
Wilson, P (2004) Estimating cardiovascular disease risk and the metabolic syndrome: a Framingham view. Endocrinology and Metabolism Clinics of North America 33, 467–481.Google Scholar
World Health Organization (1999) Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications. Part 1: Diagnosis and Classification of Diabetes Mellitus 1–59 Geneva:WHO.Google Scholar
World Health Organization (2003) Diet, Nutrition and the Prevention of Chronic Diseases. WHO Technical Report Seriesno. 916Geneva:WHO.Google Scholar